Clal Biotechnology reported ILS-5.15M in Interest Income for its fiscal quarter ending in December of 2022.





Interest Income Change Date
aTyr Pharma USD 7.84K 3.09K Sep/2025
Compugen USD 954K 116K Sep/2025
RedHill Biopharma USD 7.1M 14.49M Jun/2023